SRR598533
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- KRAS_SIGNALING_DN+0.339
- ALLOGRAFT_REJECTION+0.190
- SPERMATOGENESIS+0.171
- PANCREAS_BETA_CELLS+0.094
- MYOGENESIS-0.033
- IL6_JAK_STAT3_SIGNALING-0.038
- APICAL_SURFACE-0.042
- APICAL_JUNCTION-0.072
- INFLAMMATORY_RESPONSE-0.077
- E2F_TARGETS-0.101
Top 10 suppressed
- OXIDATIVE_PHOSPHORYLATION-0.614
- ADIPOGENESIS-0.516
- TGF_BETA_SIGNALING-0.511
- FATTY_ACID_METABOLISM-0.480
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.475
- MYC_TARGETS_V1-0.458
- NOTCH_SIGNALING-0.457
- MTORC1_SIGNALING-0.455
- CHOLESTEROL_HOMEOSTASIS-0.451
- HEDGEHOG_SIGNALING-0.438
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR602753 | GTEX | — | 0.972 |
| 2 | SRR1452056 | GTEX | — | 0.961 |
| 3 | SRR1439674 | GTEX | — | 0.952 |
| 4 | SRR1485789 | GTEX | — | 0.952 |
| 5 | SRR1471374 | GTEX | — | 0.937 |
| 6 | SRR1435884 | GTEX | — | 0.928 |
| 7 | SRR1479912 | GTEX | — | 0.927 |
| 8 | MNG555 | — | — | 0.925 |
| 9 | SRR627425 | GTEX | — | 0.925 |
| 10 | SRR8942981 | — | — | 0.919 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 4 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| KRAS_SIGNALING_DN | 0.339 | Remibrutinib | — uncovered |
| ALLOGRAFT_REJECTION | 0.190 | Idelalisib | — uncovered |
| SPERMATOGENESIS | 0.171 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.094 | Cobimetinib | — uncovered |